Amphista Therapeutics

Scottish businesses have been attracting substantial equity investment in the last year as venture capital and angel investor's interest in the region grows. Based on data from Beauhurst, the research looks at the performance of the Scottish equity investment market and compares with the other natio

Amphista Therapeutics, a University of Dundee spin-out company, has announced a £38 million investment round that will further its work to develop new drugs for a range of diseases. Amphista is a biopharmaceutical company creating first-in-class therapeutics that harness the body’s natur

Amphista Therapeutics, a University of Dundee spin-out, has announced a multi-million-pound deal to develop first-in-class cancer therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease-causing proteins. The spin-out has announced the cl